Table 2 Ovary and uterus related adverse events with positive signals for statins as a class.

From: Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System

Classification

PTs

Proportional rate ratio (PRR) by age groups (years)

Overall

0–18

19–39

40–59

≥ 60

N

PRR

χ2

N

PRR

χ2

N

PRR

χ2

N

PRR

χ2

N

PRR

χ2

Ovarian cysts and neoplasms

Ovarian adenoma

30

9.83

165.77

–

–

–

–

–

–

–

–

–

29

27.35

219.18

Cervix neoplasms

Adenocarcinoma of the cervix

–

–

–

–

–

–

–

–

–

3

9.66

11.03

–

–

–

Cervix carcinoma stage III

–

–

–

–

–

–

–

–

–

3

5.52

5.69

–

–

–

Uterine disorders (excl neoplasms)

Endometrial hyperplasia

–

–

–

–

–

–

3

8.40

12.22

–

–

–

–

–

–

Cervix disorders (excl neoplasms)

Cervix disorder

–

–

–

–

–

–

–

–

–

–

–

–

4

7.01

9.30

Cervical incompetence

–

–

–

–

–

–

3

4.50

4.90

–

–

–

–

–

–

Endocrine disorders of gonadal function

Androgenetic alopecia

21

13.25

149.00

–

–

–

–

–

–

12

17.18

99.86

7

14.31

33.62

Polycystic ovaries

–

–

–

–

–

–

5

4.10

8.60

–

–

–

–

–

–

Precocious puberty

–

–

–

3

11.05

17.82

–

–

–

–

–

–

–

–

–

Menstrual cycle and uterine bleeding disorders

Dysfunctional uterine bleeding

–

–

–

–

–

–

–

–

–

–

–

–

4

4.91

6.12

Menopause related conditions

Menopausal symptoms

–

–

–

–

–

–

–

–

–

35

2.73

32.97

–

–

–

Sexual function disorders

Dyspareunia

–

–

–

–

–

–

–

–

–

–

–

–

7

4.29

10.59

Sexual dysfunction

–

–

–

–

–

–

–

–

–

–

–

–

9

2.40

4.94

Disturbance in sexual arousal

–

–

–

–

–

–

–

–

–

6

3.44

7.05

–

–

–

Orgasm abnormal

–

–

–

–

–

–

–

–

–

4

4.91

7.32

–

–

–

  1. PTs preferred terms, PRR proportional reporting ratio, χ2 chi-square, – not a positive signal.